Our multidisciplinary research team (clinicians, computer engineers, and researchers) worked in close collaboration with an expert advisory panel (patients, representatives of breast cancer organizations, and clinicians) to develop and test the HERS app over the study period from July 2016 to June 2018. The four phases of work consisted of understanding women’s preferences and needs related to the app (phase 1), content development (phase 2), technical development (phase 3), and pilot testing (phase 4), as presented in Figure 1. The research ethics committee of Saint Mary’s Hospital Center (SMHC) in Montreal, Quebec, Canada, approved the study in June 2016 (reference number 11-22 B, amendment 3). Participants for the interviews and focus groups were recruited through breast cancer patient and community organizations and support groups, personal networks, our expert advisory committee, and social media. Informed consent was obtained from all participants.

Process of the Health Experiences and Real Stories app development. DCIS: ductal carcinoma in situ; HERS: Health Experiences and Real Stories.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.